Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Escalade | ESCA | Nov 25, 2024 | 15.56 | +2.17 |
Esco Technologies | ESE | Nov 25, 2024 | 151.38 | +1.64 |
ESGL | ESGL | Nov 25, 2024 | 1.73 | -1.16 |
ESH Acquisition | ESHA | Nov 25, 2024 | 10.66 | -0.09 |
Eshallgo | EHGO | Nov 25, 2024 | 3.92 | +4.53 |
Esperion Therapeutics | ESPR | Nov 25, 2024 | 2.57 | +1.98 |
Espey Mfg & Electronics | ESP | Nov 25, 2024 | 28.82 | -2.24 |
Esquire Financial | ESQ | Nov 25, 2024 | 77.47 | +1.27 |
ESS Tech | GWH | Nov 25, 2024 | 5.85 | -2.50 |
ESSA Bancorp | ESSA | Nov 25, 2024 | 20.51 | +1.03 |
ESSA Pharma | EPIX | Nov 25, 2024 | 1.80 | -1.64 |
Essent Group | ESNT | Nov 25, 2024 | 58.12 | +2.40 |
Essential Properties Realty Trust | EPRT | Nov 25, 2024 | 33.82 | +1.05 |
Essential Utilities | WTRG | Nov 25, 2024 | 40.11 | +1.47 |
Essex Property Trust | ESS | Nov 25, 2024 | 309.60 | +1.33 |
Establishment Labs | ESTA | Nov 25, 2024 | 45.55 | +5.73 |
Estee Lauder Companies | EL | Nov 25, 2024 | 72.97 | +4.35 |
Estrella Immunopharma | ESLA | Nov 25, 2024 | 1.00 | +9.89 |
Eterna Therapeutics | ERNA | Nov 25, 2024 | 0.51 | -1.15 |
ETFMG Alternative Harvest ETF | MJ | Nov 25, 2024 | 2.61 | +3.57 |
Ethan Allen Interiors | ETD | Nov 25, 2024 | 31.04 | +3.71 |
Eton Pharmaceuticals | ETON | Nov 25, 2024 | 12.03 | +7.12 |
Etsy | ETSY | Nov 25, 2024 | 55.68 | +6.46 |
Euda Health | EUDA | Nov 25, 2024 | 4.32 | -4.59 |
Eupraxia Pharmaceuticals | EPRX | Nov 25, 2024 | 3.41 | -2.29 |
Eureka Acquisition | EURKU | Nov 25, 2024 | 10.29 | 0.00 |
Eureka Acquisition | EURK | Nov 25, 2024 | 10.11 | 0.00 |
Euro Tech Holdings | CLWT | Nov 25, 2024 | 1.45 | +1.40 |
Euro Trust | FXE | Nov 25, 2024 | 96.93 | +0.78 |
EuroDry | EDRY | Nov 25, 2024 | 13.34 | -5.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.